vs

Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and HEALTHCARE SERVICES GROUP INC (HCSG). Click either name above to swap in a different company.

HEALTHCARE SERVICES GROUP INC is the larger business by last-quarter revenue ($466.7M vs $397.6M, roughly 1.2× Guardian Pharmacy Services, Inc.).

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.

GRDN vs HCSG — Head-to-Head

Bigger by revenue
HCSG
HCSG
1.2× larger
HCSG
$466.7M
$397.6M
GRDN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GRDN
GRDN
HCSG
HCSG
Revenue
$397.6M
$466.7M
Net Profit
$20.9M
Gross Margin
21.5%
15.4%
Operating Margin
7.7%
6.1%
Net Margin
5.3%
Revenue YoY
6.6%
Net Profit YoY
EPS (diluted)
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRDN
GRDN
HCSG
HCSG
Q4 25
$397.6M
$466.7M
Q3 25
$377.4M
$464.3M
Q2 25
$344.3M
$458.5M
Q1 25
$329.3M
$447.7M
Q4 24
$437.8M
Q3 24
$314.4M
$428.1M
Q2 24
$426.3M
Q1 24
$423.4M
Net Profit
GRDN
GRDN
HCSG
HCSG
Q4 25
$20.9M
Q3 25
$9.8M
$43.0M
Q2 25
$9.0M
$-32.4M
Q1 25
$9.4M
$17.2M
Q4 24
Q3 24
$-122.0M
$14.0M
Q2 24
$-1.8M
Q1 24
$15.3M
Gross Margin
GRDN
GRDN
HCSG
HCSG
Q4 25
21.5%
15.4%
Q3 25
19.8%
20.8%
Q2 25
19.8%
0.6%
Q1 25
19.5%
15.2%
Q4 24
13.4%
Q3 24
19.4%
14.8%
Q2 24
9.7%
Q1 24
15.2%
Operating Margin
GRDN
GRDN
HCSG
HCSG
Q4 25
7.7%
6.1%
Q3 25
4.3%
12.3%
Q2 25
3.7%
-9.1%
Q1 25
3.9%
5.3%
Q4 24
3.4%
Q3 24
-33.3%
4.4%
Q2 24
-0.5%
Q1 24
5.0%
Net Margin
GRDN
GRDN
HCSG
HCSG
Q4 25
5.3%
Q3 25
2.6%
9.3%
Q2 25
2.6%
-7.1%
Q1 25
2.9%
3.8%
Q4 24
Q3 24
-38.8%
3.3%
Q2 24
-0.4%
Q1 24
3.6%
EPS (diluted)
GRDN
GRDN
HCSG
HCSG
Q4 25
$0.43
Q3 25
$0.59
Q2 25
$-0.44
Q1 25
$0.23
Q4 24
$0.15
Q3 24
$0.19
Q2 24
$-0.02
Q1 24
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRDN
GRDN
HCSG
HCSG
Cash + ST InvestmentsLiquidity on hand
$65.6M
$168.0M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$217.9M
$510.2M
Total Assets
$412.7M
$794.3M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRDN
GRDN
HCSG
HCSG
Q4 25
$65.6M
$168.0M
Q3 25
$36.5M
$177.5M
Q2 25
$18.8M
$134.5M
Q1 25
$14.0M
$114.8M
Q4 24
$107.3M
Q3 24
$37.2M
$103.8M
Q2 24
$105.6M
Q1 24
$104.9M
Total Debt
GRDN
GRDN
HCSG
HCSG
Q4 25
$0
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$34.3M
Q2 24
Q1 24
Stockholders' Equity
GRDN
GRDN
HCSG
HCSG
Q4 25
$217.9M
$510.2M
Q3 25
$195.5M
$496.0M
Q2 25
$179.7M
$477.0M
Q1 25
$163.2M
$514.2M
Q4 24
$499.9M
Q3 24
$133.9M
$488.7M
Q2 24
$471.4M
Q1 24
$474.6M
Total Assets
GRDN
GRDN
HCSG
HCSG
Q4 25
$412.7M
$794.3M
Q3 25
$390.0M
$804.3M
Q2 25
$356.3M
$802.2M
Q1 25
$334.0M
$823.0M
Q4 24
$802.8M
Q3 24
$348.0M
$805.8M
Q2 24
$799.7M
Q1 24
$803.9M
Debt / Equity
GRDN
GRDN
HCSG
HCSG
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.26×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRDN
GRDN
HCSG
HCSG
Operating Cash FlowLast quarter
$34.6M
$17.4M
Free Cash FlowOCF − Capex
$16.0M
FCF MarginFCF / Revenue
3.4%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$139.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRDN
GRDN
HCSG
HCSG
Q4 25
$34.6M
$17.4M
Q3 25
$28.2M
$71.3M
Q2 25
$19.9M
$28.8M
Q1 25
$17.6M
$27.5M
Q4 24
$36.2M
Q3 24
$4.3M
Q2 24
$16.3M
Q1 24
$-26.0M
Free Cash Flow
GRDN
GRDN
HCSG
HCSG
Q4 25
$16.0M
Q3 25
$24.2M
$70.0M
Q2 25
$27.4M
Q1 25
$25.8M
Q4 24
$34.8M
Q3 24
$2.9M
Q2 24
$15.0M
Q1 24
$-28.2M
FCF Margin
GRDN
GRDN
HCSG
HCSG
Q4 25
3.4%
Q3 25
6.4%
15.1%
Q2 25
6.0%
Q1 25
5.8%
Q4 24
7.9%
Q3 24
0.7%
Q2 24
3.5%
Q1 24
-6.7%
Capex Intensity
GRDN
GRDN
HCSG
HCSG
Q4 25
0.3%
Q3 25
1.1%
0.3%
Q2 25
0.3%
Q1 25
0.4%
Q4 24
0.3%
Q3 24
0.3%
Q2 24
0.3%
Q1 24
0.5%
Cash Conversion
GRDN
GRDN
HCSG
HCSG
Q4 25
1.65×
Q3 25
2.87×
1.66×
Q2 25
2.21×
Q1 25
1.86×
1.60×
Q4 24
Q3 24
0.31×
Q2 24
Q1 24
-1.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRDN
GRDN

Segment breakdown not available.

HCSG
HCSG

Dietary Services$255.9M55%
Other$210.8M45%

Related Comparisons